We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $5.05B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
+18.47%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$5.6B
AUM Growth
+$886M
Cap. Flow
+$142M
Cap. Flow %
2.54%
Top 10 Hldgs %
40.08%
Holding
154
New
29
Increased
38
Reduced
31
Closed
27

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$93.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$82.6M
3
SHPG
Shire pic
SHPG
+$76.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.3M
5
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$49.2M

Top Sells

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$149M
2
INCY icon
Incyte
INCY
+$33.4M
3
MAKO
MAKO SURGICAL CORP COM
MAKO
+$26.7M
4
PFE icon
Pfizer
PFE
+$25.6M
5
AGN
Allergan plc
AGN
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 83.56%
2 Financials 1.77%
3 Technology 0.15%
4 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
26
DELISTED
Allergan plc
AGN
$68.4M 1.22%
475,100
-178,100
-27% -$23.7M
IPXL
27
DELISTED
Impax Laboratories, Inc.
IPXL
$67.3M 1.2%
3,285,700
+25,100
+0.8% +$518K
MOH icon
28
Molina Healthcare
MOH
$10.6B
$65.3M 1.17%
1,834,000
+169,000
+10% +$6.24M
CBST
29
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$57.5M 1.03%
904,200
+814,200
+905% +$49.2M
JNJ icon
30
Johnson & Johnson
JNJ
$645B
$56.6M 1.01%
653,000
+452,000
+225% +$40.5M
WCRX
31
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$56.2M 1%
2,449,100
-304,000
-11% -$6.43M
EXAS
32
DELISTED
Exact Sciences
EXAS
$55.2M 0.99%
4,680,300
-21,600
-0.5% -$277K
EXEL icon
33
Exelixis
EXEL
$14B
$50.9M 0.91%
+8,744,000
New +$45.3M
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$775B
$50.4M 0.9%
+300,000
New +$50.3M
ITMN
35
DELISTED
INTERMUNE INC
ITMN
$44.4M 0.79%
2,887,600
+2,651,600
+1,124% +$37.2M
CFN
36
DELISTED
CAREFUSION CORPORATION
CFN
$44.4M 0.79%
1,203,300
+1,048,400
+677% +$39.1M
AFFX
37
DELISTED
Affymetrix Inc
AFFX
$41.2M 0.73%
6,648,000
+272,600
+4% +$1.41M
NXTM
38
DELISTED
NxStage Medical Inc.
NXTM
$41M 0.73%
3,114,500
-106,600
-3% -$1.4M
HNT
39
DELISTED
HEALTH NET INC
HNT
$40.2M 0.72%
1,269,600
+619,600
+95% +$19.6M
ALGN icon
40
Align Technology
ALGN
$12.8B
$36.8M 0.66%
766,000
-58,000
-7% -$2.53M
CI icon
41
Cigna
CI
$79.1B
$33.7M 0.6%
438,000
+11,000
+3% +$859K
SPY icon
42
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$775B
$33.6M 0.6%
200,000
-100,000
-33% -$16.8M
LAB icon
43
Standard BioTools
LAB
$325M
$31.1M 0.55%
1,416,608
+153,900
+12% +$3.02M
ARRY
44
DELISTED
Array Biopharma Inc
ARRY
$30.1M 0.54%
4,831,600
-33,400
-0.7% -$198K
OSUR icon
45
OraSure Technologies
OSUR
$275M
$29.2M 0.52%
4,860,100
+99,800
+2% +$500K
AGN
46
DELISTED
Allergan Inc
AGN
$26.9M 0.48%
297,000
-5,000
-2% -$449K
CNC icon
47
Centene
CNC
$31.3B
$26.8M 0.48%
1,673,200
– –
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$124B
$25.6M 0.46%
338,000
+115,000
+52% +$9.15M
ALXN
49
DELISTED
Alexion Pharmaceuticals
ALXN
$25.1M 0.45%
215,900
+23,000
+12% +$2.52M
XNPT
50
DELISTED
XENOPORT, INC.
XNPT
$24M 0.43%
4,222,600
+181,800
+4% +$949K
1
2
3 4 5

Similar funds

HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.02B AUM 21.87% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return

OrbiMed's Q3 2013 Portfolio in Review

As of Q3 2013, OrbiMed held 154 positions worth $5.6B, up 19% from $4.72B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

OrbiMed's Q3 2013 filing shows 29 new, 38 increased, 31 reduced and 27 closed positions. Its largest new stake was Shire pic: 690,900 shares worth $82.8M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $149M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 80% a quarter earlier, followed by Financials and Technology.

  • OrbiMed's largest Q3 2013 buy was Shire pic: 690,900 shares worth $82.8M.
  • OrbiMed added most to Merck in Q3 2013, an estimated $93.3M increase.
  • OrbiMed's biggest Q3 2013 reduction was Incyte, cutting an estimated $33.4M.
  • OrbiMed fully exited ONYX PHARMACEUTICALS INC in Q3 2013, selling an estimated $149M.
  • OrbiMed's ten largest holdings make up 40% of its $5.6B portfolio in Q3 2013.
  • OrbiMed opened 29 new positions and closed 27 in Q3 2013.
  • OrbiMed's portfolio value rose 19% quarter-over-quarter to $5.6B.

Based on OrbiMed's 13F filing for Q3 2013, filed 14 Nov 2013.